Evidence map›Paper›PMID 34443521›Full record

ReviewMolecules (Basel, Switzerland)2021

Can Eucalyptol Replace Antibiotics?

Wanda Mączka, Anna Duda-Madej, Aleksandra Górny, Małgorzata Grabarczyk, Katarzyna Wińska

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Metabolomic Insights into the Antimicrobial Effects ofMolecules (Basel, Switzerland) · 2025
    Article
  15. Article
  16. Investigating the Health Potential ofPharmaceuticals (Basel, Switzerland) · 2025
    Review
  17. Review
  18. Phytochemicals Controlling EnterohemorrhagicInternational journal of molecular sciences · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wanda MączkaDepartment of Chemistry, Wroclaw University of Environmental and Life Sciences, Norwida 25, 50-375 Wrocław, Poland.ORCID 0000-0003-2960-2438
Anna Duda-MadejDepartment of Microbiology, Wroclaw Medical University, Chałubińskiego 4, 50-368 Wrocław, Poland.
Aleksandra GórnyDepartment of Chemistry, Wroclaw University of Environmental and Life Sciences, Norwida 25, 50-375 Wrocław, Poland.
Małgorzata GrabarczykDepartment of Chemistry, Wroclaw University of Environmental and Life Sciences, Norwida 25, 50-375 Wrocław, Poland.ORCID 0000-0002-1097-7216
Katarzyna WińskaDepartment of Chemistry, Wroclaw University of Environmental and Life Sciences, Norwida 25, 50-375 Wrocław, Poland.ORCID 0000-0003-2320-6610

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the primary reasons for the search for new antimicrobial agents is the increasing and spreading resistance of microorganisms to previously used drugs. This is particularly important in the case of rapidly progressing infections that require the rapid administration of an appropriately selected antibiotic. However, along with the administration of antibiotics, complications in the disease-weakened body may arise in the form of systemic mycoses, viral infections, and protozoan infections. Therefore, there is an increasing interest among researchers focusing on the use of naturally occurring terpenic compounds in stand-alone or combined therapies with antibiotics. In this publication, the aim of our work is to present the results of a literature review on the antimicrobial activity of eucalyptol.

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsDrug Resistance, BacterialEucalyptolHumansMycosesAnti-Bacterial AgentsAnti-Infective AgentsEucalyptol1,8-cineoleantimicrobial activityeucalyptol

Identifiers

PMID34443521
PMCPMC8398027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.